Product Images Ramipril

The text appears to be a graph displaying the proportion of patients who received placebo versus ramipril over a certain period of time. The X-axis displays the duration of follow-up in days, while the Y-axis displays the proportion of patients. The legend shows that the blue line represents the proportion of patients who received placebo, while the red line represents the proportion of patients who received ramipril. The graph suggests that the proportion of patients who received ramipril was significantly higher than the proportion of patients who received placebo after around 400 days of follow-up.*

This appears to be a table displaying the incidence of a composite outcome and various health conditions (such as cardiovascular disease, diabetes, hypertension, etc.) in a placebo group. There are also columns for the number of patients in the placebo group and for the relative risk in a Ramipril group, along with a confidence interval. There is no data given for the Ramipril group itself.*

This is a package insert that provides prescribing information for a drug with the National Drug Code 68180-589-09. The drug is a capsule containing 2.5mg of ramipril USP. The product is manufactured by Lupin Limited in India and distributed by Lupin Pharmaceuticals, Inc. in the United States. The insert includes a warning to keep the drug out of reach of children and advises pharmacists to dispense it in a light-resistant, tight container with a child-resistant closure. The recommended storage temperature is between 20°C and 25°C.*

This text is a prescription drug label for Ramipril Capsules, manufactured by Lupin Pharmaceuticals. It contains dosage instructions and administration details for the drug. It also includes a warning to keep the drug out of the reach of children and to store it in a light-resistant, tight container. Each capsule contains 5mg of Ramipril USP. The label also provides information on where the drug was manufactured and the code number of the drugs.*

This text is a package insert for prescribing information of a drug called ramipril, with NDC number 68180-591-09. The drug is manufactured by Lupin Pharmaceuticals, Inc. and each capsule of the drug contains 10 mg of ramipril USP. The text also provides instructions for dosage and administration of the drug, including warnings such as keeping it out of reach of children and storing it in a light-resistant and tight container with a child-resistant closure at a controlled room temperature between 20° to 25°C (68° to 77°F). The package contains 90 capsules.*

This is a product description for Ramipril capsules with 2.5mg of amiprl USP. The dosage instructions are not provided, and a warning is given to keep it out of reach. There are 90 capsules in the container, and it is manufactured by LUPIN. The rest of the text is not legible.*

This is a package insert for a medication with the NDC code 68180-590-09. The medication is Ramipril and it is available in capsule form. It is advised to keep the medication out of the reach of children. The capsules are USP and are packaged in a resistant and high-quality container with a child-resistant closure. The recommended storage temperature is 20° to 25°C (68° to 77°F). Each capsule contains 5 mg of Ramipril. The medication is manufactured by Lupin Limited and is only available for prescription in the United States.*

This is a package insert for the prescription drug Ramipril. It contains a warning to keep it out of reach of children, and instructions for dosage and administration. The capsules come in a sealed container and must be stored at a specific temperature range. Each capsule contains 10 mg of the active ingredient, Ramipril USP. The drug is manufactured by Lupin Limited and is available in a bottle containing 90 capsules.*